Hm Payson & CO Eli Lilly & CO Transaction History

Hm Payson & CO

$5.81 Billion
Q3 2024

A detailed history of Hm Payson & CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Hm Payson & CO holds 21,953 shares of LLY stock, worth $18.1 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

21,953

Previous 21,575 1.75%

Holding current value

$18.1 Million

Previous $19.5 Million 0.43%

% of portfolio

0.33%

Previous 0.36%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$772.14 - $960.02 $291,868 - $362,887	378 Added 1.75%	21,953 $19.4 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $1.45 Million - $1.82 Million	-2,002 Reduced 8.49%	21,575 $19.5 Million
Q1 2024 Jun 20, 2024	SELL	$592.2 - $792.28 $487,380 - $652,046	-823 Reduced 3.37%	23,577 $18.3 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $594,515 - $700,855	-1,132 Reduced 4.43%	24,400 $14.2 Million
Q3 2023 Nov 06, 2023	BUY	$434.7 - $599.3 $467,302 - $644,247	1,075 Added 4.4%	25,532 $13.7 Million
Q2 2023 Jul 17, 2023	BUY	$350.74 - $468.98 $1.1 Million - $1.48 Million	3,146 Added 14.76%	24,457 $11.5 Million
Q1 2023 Apr 18, 2023	BUY	$310.63 - $364.82 $441,094 - $518,044	1,420 Added 7.14%	21,311 $7.32 Million
Q4 2022 Feb 06, 2023	SELL	$321.55 - $374.67 $648,244 - $755,334	-2,016 Reduced 9.2%	19,891 $7.28 Million
Q3 2022 Oct 25, 2022	BUY	$296.48 - $337.87 $88,647 - $101,023	299 Added 1.38%	21,907 $7.08 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $17,002 - $19,963	-61 Reduced 0.28%	21,608 $7.01 Million
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $17,367 - $21,582	74 Added 0.34%	21,669 $6.21 Million
Q4 2021 Feb 15, 2022	SELL	$224.85 - $279.04 $87,241 - $108,267	-388 Reduced 1.77%	21,595 $5.97 Million
Q3 2021 Nov 30, 2021	BUY	$221.6 - $272.71 $436,773 - $537,511	1,971 Added 9.85%	21,983 $5.08 Million
Q2 2021 Aug 17, 2021	BUY	$180.55 - $233.54 $32,137 - $41,570	178 Added 0.9%	20,012 $4.59 Million
Q1 2021 Jun 15, 2021	SELL	$164.32 - $212.72 $40,422 - $52,329	-246 Reduced 1.23%	19,834 $3.71 Million
Q4 2020 Mar 10, 2021	SELL	$130.46 - $172.63 $240,959 - $318,847	-1,847 Reduced 8.42%	20,080 $3.39 Million
Q3 2020 Dec 21, 2020	SELL	$146.22 - $169.13 $32,168 - $37,208	-220 Reduced 0.99%	21,927 $3.25 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $22,645 - $27,253	-166 Reduced 0.74%	22,147 $3.64 Million
Q1 2020 Jul 01, 2020	SELL	$119.05 - $147.35 $75,596 - $93,567	-635 Reduced 2.77%	22,313 $3.1 Million
Q4 2019 Feb 18, 2020	SELL	$106.92 - $132.43 $25,126 - $31,121	-235 Reduced 1.01%	22,948 $3.02 Million
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $3,737 - $4,065	35 Added 0.15%	23,183 $2.59 Million
Q2 2019 Aug 15, 2019	SELL	$110.79 - $129.32 $26,700 - $31,166	-241 Reduced 1.03%	23,148 $2.57 Million
Q1 2019 Jul 31, 2019	BUY	$111.31 - $131.02 $2.6 Million - $3.06 Million	23,389 New	23,389 $3.04 Million
Q4 2018 Feb 15, 2019	SELL	$105.9 - $118.64 $2.53 Million - $2.83 Million	-23,891 Closed	0 $0
Q3 2018 Nov 30, 2018	SELL	$85.86 - $107.31 $50,829 - $63,527	-592 Reduced 2.42%	23,891 $2.56 Million
Q2 2018 Aug 27, 2018	SELL	$75.7 - $86.88 $87,130 - $99,998	-1,151 Reduced 4.49%	24,483 $2.09 Million
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $2,745 - $3,241	37 Added 0.14%	25,634 $1.98 Million
Q4 2017 Feb 16, 2018	SELL	$81.94 - $87.89 $140,281 - $150,467	-1,712 Reduced 6.27%	25,597 $2.16 Million
Q3 2017 Nov 06, 2017	BUY	$77.07 - $85.54 $2.1 Million - $2.34 Million	27,309	27,309 $2.34 Million

Others Institutions Holding LLY

# of Institutions

4,091

Shares Held

737M

Call Options Held

8.26M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $785B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.

Account